Ducks captain Ryan Getzlaf
is hosting the third annual Getzlaf Golf Shootout on September 7-8 benefiting CureDuchenne. The Getzlaf Golf Shootout is an opportunity to interact with your favorite players, play golf and support a great cause.
This two-day charity golf event includes a reception at Sutra Lounge in Costa Mesa and a golf tournament held at the Monarch Beach Golf Links in Dana Point. Each foursome will be teamed up with a professional athlete or celebrity for a unique and exciting day on the green.
CureDuchenne is a nonprofit based in Newport Beach that raises awareness and funds research for Duchenne muscular dystrophy. Duchenne is a progressive muscle-wasting disease that impacts one in every 3,500 boys. Boys are usually diagnosed at age 5, are in a wheelchair by 12 and most don’t live past their mid-20s. Currently there is no cure for Duchenne.
“Duchenne is a devastating disease that impacts boys and robs them of the ability to walk, run and play sports,” said Getzlaf. “My wife, Paige, and I are committed to support CureDuchenne and their efforts in finding a cure for Duchenne. It is urgent to find a cure now in order to give these boys a chance. We hope you’ll join us at the golf tournament and provide hope for the 300,000 boys living with Duchenne.”
The Getzlaf Golf Shootout brings together athletes, celebrities and community leaders teaming up in support of CureDuchenne. The course will include a variety of fun activities including a hockey stick putting contest, longest drive contest and dunk tank as well as plenty of food and drink.
Foursomes cost $2,800 and include a celebrity or athlete as a fifth golfer plus eight tickets to the pre-golf dinner reception. Meet and mingle with hockey players at the reception on September 7 at Sutra. There will be a live and silent auction. Individual tickets to the reception are $100. Click here to register now. For sponsorship information, please contact Karen Harley, 949-872-2552 or email@example.com.
CureDuchenne has funded seven research projects that have gone into human clinical trials. All the funds raised will support the most promising research to find a cure for Duchenne.